Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
- PMID: 32025602
- PMCID: PMC6996345
- DOI: 10.1002/hep4.1460
Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
Abstract
The hepatitis B virus (HBV) is an important human pathogen. Unvaccinated infants infected through mother-to-child transmission (MTCT) are at >95% risk of developing serum hepatitis B surface antigen-positive chronic hepatitis B (CHB). Despite complete passive-active HBV immunoprophylaxis, approximately 10% of infants born to mothers who are highly viremic develop CHB, and thus maternal treatment with nucleos(t)ide analogs (tenofovir disoproxil fumarate, lamivudine, or telbivudine) is recommended in the third trimester of pregnancy to reduce MTCT risk. Viral rebound usually occurs after stopping treatment and, in the context of maternal immunologic reconstitution postpartum, can also precipitate host immune-mediated hepatic (biochemical) flares. In this article, we review the epidemiology of HBV MTCT, discuss management and potential mechanisms of HBV vertical transmission, and highlight recent studies on virologic and immunologic aspects of hepatitis B in pregnancy and postpartum.
© 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.
Figures
References
-
- World Health Organization . Global health sector strategy on viral hepatitis 2016‐2021. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Published June 2016. Accessed September 2019.
-
- World Health Organization . Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Published July 18, 2019. Accessed August 2019.
-
- Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol 2017;31:239‐247. - PubMed
-
- Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, et al. Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Can Liver J 2018;1:156‐217. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources